• Home
• Research
• Specialized Working Groups
• Adult Acute Lymphoblastic Leukemia
• Publications

Publications

• Management of ALL in Adults: 2023 ELN Recommendations from a European Expert Panel
  Gökbuget N, Boissel N, Chiaretti S, Dombret H, Doubek M, Fielding AK, Foà R, Giebel S, Hoelzer D, Hunault M, Marks DI, Martinelli G, Ottmann O, Rijneveld AW, Rousselot P, Ribera JM, Bassan R.
  Blood. 2024 Feb 2:blood.2023023568.Epub ahead of print. PMID: 38306595.
  
  
• ESMO Clinical Practice Guideline interim update on the use of targeted therapy in acute lymphoblastic leukemia
  D. Hoelzer, R. Bassan, N. Boissel, C. Roddie, JM. Ribera, M. Jerkeman, on behalf of the ESMO Guidelines Committee.
  Ann Oncol. 2024; 35(1):15-28.
  
  
• A robust and validated integrated prognostic index for determining post-induction therapy in adult acute lymphoblastic leukemia: A European Working Group for Adult Acute Lymphoblastic Leukemia (EWALL) collaborative study
  Enshaei A, Joy M, Butler E, Kirkwood AA, Messina M, Pavoni C, Morgades M, Harrison CH, Ribera JM, Chiaretti S, Bassan R, Fielding AK, Moorman AV.
  Blood Adv. 2024;8(5):1155-1166.